Millipore Sigma Vibrant Logo

AB5932 Anti-Potassium Channel KvLQT1 Antibody, CT

View Products on Sigmaaldrich.com
AB5932
100 µg  
正在检索价格......
无法检索价格。
最小订购数量为倍数
Maximum Quantity is
以订单确认为准 更多信息
您节约了 ()。
 
Request Pricing
目前缺货
目前缺货
有货 
停产
少量现货
供货情况有待确认
    其余:另行通知
      其余:另行通知
      另行通知
      联系客户服务
      Contact Customer Service

      特卖

       

      联系客户服务

      概述

      Replacement Information

      重要规格表

      Species ReactivityKey ApplicationsHostFormatAntibody Type
      H, M, RIHC, WBRbAffinity PurifiedPolyclonal Antibody
      Description
      Catalogue NumberAB5932
      Brand Family Chemicon®
      Trade Name
      • Chemicon
      DescriptionAnti-Potassium Channel KvLQT1 Antibody, CT
      Alternate Names
      • IKs producing slow voltage-gated potassium channel subunit alpha KvLQT1
      • KQT-like 1
      • Voltage-gated potassium channel subunit Kv7.1
      • kidney and cardiac voltage dependent K+ channel
      • potassium voltage-gated channel, KQT-like subfamily, member 1
      • slow delayed rectifier channel subunit
      Background InformationKvLQT1(Kv7.1) is a voltage-gated potassium channel protein coded for by the gene KCNQ1. This protein is present in the cell membranes of cardiac muscle tissue and in inner ear neurons among other tissues. KvLQT1 can form heteromultimers with two other potassium channel proteins, KCNE1 and KCNE3 and in heart cells is required for the repolarization phase of the cardiac action potential. Mutations in the gene are associated with hereditary long QT syndrome, Romano-Ward syndrome, Jervell and Lange-Nielsen syndrome and familial atrial fibrillation, lead to a defective KvLQT1 protein and several forms of inherited arrhythmias known as Long QT syndrome, Short QT syndrome, and Familial Atrial Fibrillation.
      References
      Product Information
      FormatAffinity Purified
      Control
      • Human heart tissue lysate
      PresentationPurified rabbit polyclonal in buffer containing 0.1 M Tris-Glycine (pH 7.4, 150 mM NaCl) with 0.05% sodium azide.
      Quality LevelMQ100
      Applications
      ApplicationAnti-Potassium Channel KvLQT1 Antibody, C-terminus detects level of Potassium Channel KvLQT1 & has been published & validated for use in IH & WB.
      Key Applications
      • Immunohistochemistry
      • Western Blotting
      Application NotesImmunohistochemistry Analysis: 1:300 dilution from a previous lot detected Potassium Channel KvLQT1 in human myocardium tissue.

      /Western Blotting Analysis: 2 μg/mL of this
      antibody detected KvLQT1 in 10 μg of human
      heart tissue lysate.

      Optimal working dilutions must be determined by end user.
      Biological Information
      ImmunogenKLH-conjugated linear peptide from the C-terminus of human KvLQT1.
      EpitopeC-terminus
      ConcentrationPlease refer to the Certificate of Analysis for the lot-specific concentration.
      HostRabbit
      SpecificityThis antibody recognizes Potassium Channel KvLQT1 protein.
      Species Reactivity
      • Human
      • Mouse
      • Rat
      Species Reactivity NoteDemonstrated to react with human. Predicted to react with rat and mouse based on 100% sequence homology.
      Antibody TypePolyclonal Antibody
      Entrez Gene Number
      Entrez Gene SummaryThis gene encodes a protein for a voltage-gated potassium channel required for the repolarization phase of the cardiac action potential. The gene product can form heteromultimers with two other potassium channel proteins, KCNE1 and KCNE3. Mutations in this gene are associated with hereditary long QT syndrome, Romano-Ward syndrome, Jervell and Lange-Nielsen syndrome and familial atrial fibrillation. The gene is located in a region of chromosome 11 that contains a large number of contiguous genes that are abnormally imprinted in cancer and the Beckwith-Wiedemann syndrome. Two alternative transcripts encoding distinct isoforms have been described.
      Gene Symbol
      • KCNQ1
      • JLNS1
      • ATFB1
      • SQT2
      • CNA8
      • LQT
      • WRS
      • Kv1.9
      • KVLQT1
      • RWS
      • Kv7.1
      • KCNA9
      • QTS
      • LQT1
      Purification MethodAffinity Purfied
      UniProt Number
      UniProt SummaryFUNCTION: Probably important in cardiac repolarization. Associates with KCNE1 (MinK) to form the I(Ks) cardiac potassium current. Elicits a rapidly activating, potassium-selective outward current. Muscarinic agonist oxotremorine-M strongly suppresses KCNQ1/KCNE1 current in CHO cells in which cloned KCNQ1/KCNE1 channels were coexpressed with M1 muscarinic receptors. May associate also with KCNE3 (MiRP2) to form the potassium channel that is important for cyclic AMP-stimulated intestinal secretion of chloride ions, which is reduced in cystic fibrosis and pathologically stimulated in cholera and other forms of secretory diarrhea.

      SIZE: 676 amino acids; 74699 Da

      SUBUNIT: Heteromultimer with KCNE1 (MinK) or KCNE3 (MiRP2).

      SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.

      TISSUE SPECIFICITY: Abundantly expressed in heart, pancreas, prostate, kidney, small intestine and peripheral blood leukocytes. Less abundant in placenta, lung, spleen, colon, thymus, testis and ovaries.

      DOMAIN: The segment S4 is probably the voltage-sensor and is characterized by a series of positively charged amino acids at every third position.

      DISEASE: Defects in KCNQ1 are the cause of long QT syndrome type 1 (LQT1) [MIM:192500]; also known as Romano-Ward syndrome (RWS). Long QT syndromes are heart disorders characterized by a prolonged QT interval on the ECG and polymorphic ventricular arrhythmias. They cause syncope and sudden death in response to exercise or emotional stress. LQT1 inheritance is an autosomal dominant. & Defects in KCNQ1 are a cause of Jervell and Lange-Nielsen syndrome (JLNS) [MIM:220400]. JLNS is an autosomal recessive cardio-auditory syndrome characterized by a prolonged QT interval in the electrocardiogram and congenital deafness. & Defects in KCNQ1 are the cause of atrial fibrillation type 1 (ATFB1) [MIM:607554]. ATFB is characterized by rapid and irregular activation of the atrium. ATFB causes thromboembolism, tachycardia-mediated cardiomyopathy, heart failure and ventricular arrhythmia. & Defects in KCNQ1 are the cause of short QT syndrome type 2 (SQT2) [MIM:609621]. Short QT syndromes are heart disorders characterized by idiopathic persistently and uniformly short QT interval on ECG in the absence of structural heart disease in affected individuals. They cause syncope and sudden death.

      SIMILARITY: Belongs to the potassium channel family. KQT subfamily.

      MISCELLANEOUS: Mutagenesis experiments were carried out by expressing in Xenopus oocytes or COS-7 cells KCNQ1 mutants either individually (homomultimers) or in combination with both wild-type KCNQ1 (mut/wt homomultimers) and minK (heteromultimers).
      Molecular Weight~ 72 kDa Observed
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Quality AssuranceEvaluated by Western Blot in human heart tissue lysate.

      Western Blot Analysis: 2 µg/ml of this antibody detected KvLQT1 in 10 µg of human heart tissue lysate.
      Usage Statement
      • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
      Storage and Shipping Information
      Storage ConditionsStable for 1 year at 2-8°C from date of receipt.
      Packaging Information
      Material Size100 µg
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      产品目录编号 GTIN
      AB5932 04053252327056

      Documentation

      Anti-Potassium Channel KvLQT1 Antibody, CT MSDS

      职位

      物料安全数据表 (MSDS) 

      Anti-Potassium Channel KvLQT1 Antibody, CT 分析证书

      标题批号
      Anti-Potassium Channel KvLQT1, C-terminus - 2118017 2118017
      Anti-Potassium Channel KvLQT1, -2743623 2743623
      Anti-Potassium Channel KvLQT1, -2826964 2826964
      Anti-Potassium Channel KvLQT1, C-terminus - 1951923 1951923
      Anti-Potassium Channel KvLQT1, C-terminus - 2194066 2194066
      Anti-Potassium Channel KvLQT1, C-terminus - 2246760 2246760
      Anti-Potassium Channel KvLQT1, C-terminus - 2361816 2361816
      Anti-Potassium Channel KvLQT1, C-terminus - 2828350 2828350
      Anti-Potassium Channel KvLQT1, C-terminus - 3204842 3204842
      Anti-Potassium Channel KvLQT1, C-terminus - 3387612 3387612

      参考

      参考概述公共医疗ID
      Lipopolysaccharide-induced inflammation attenuates taste progenitor cell proliferation and shortens the life span of taste bud cells.
      Cohn, ZJ; Kim, A; Huang, L; Brand, J; Wang, H
      BMC neuroscience  11  72  2010

      显示摘要
      20537148 20537148
      Kcnq1 contributes to an adrenergic-sensitive steady-state K+ current in mouse heart.
      Bjorn C Knollmann, Syevda Sirenko, Qi Rong, Alexander N Katchman, Mathew Casimiro, Karl Pfeifer, Steven N Ebert
      Biochemical and biophysical research communications  360  212-8  2007

      显示摘要 全文本文章
      17597584 17597584
      The KCNE2 potassium channel ancillary subunit is essential for gastric acid secretion.
      Roepke, TK; Anantharam, A; Kirchhoff, P; Busque, SM; Young, JB; Geibel, JP; Lerner, DJ; Abbott, GW
      The Journal of biological chemistry  281  23740-7  2006

      显示摘要
      16754665 16754665